Skip to main content
. 2012 Oct 15;186(8):752–762. doi: 10.1164/rccm.201202-0302OC

Figure 6.

Figure 6.

Tenascin C is increased in bleomycin-exposed matrix metalloproteinase (Mmp)19-deficient mice. (A) Lungs from control mice and 21-day bleomycin-instilled mice were homogenized in RIPA lysis buffer, and tenascin C was analyzed by Western blot. (B) Densitometric analysis of the bands of tenascin C normalized with β-tubulin. Results are presented as mean ± SD from two independent experiments; *P < 0.01, **P < 0.02. (C, D) Immunohistochemical evaluation of tenascin C in Mmp19+/+ (C) and Mmp19−/− (D) mice. Pictures are representative of three WT and three MMP-19–deficient mice.